Looks like everyone is freaking out howeverthis whole story really is based on FDA approval. Financially this doesn't look good, that's obvious. The science is good, that's also obvious.
I've heard a lot of people saying they have nothing until approval, that's also true and obvious. But it works both ways as all it takes is one YES from the FDA and this stock is back where it used to be.
This has been the gamble we all made as longs from day 1. The roller coaster an volitility comes with the potential reward. Everyone was quick to talk about minimum 20$ per share just to concider a buyout. Well high risk, high reward. And that's a pretty f^38in high reward...
Just look at how the stock tanked and then came back and finished green all within 2h. Literally on 0 new information. It's all smoke an mirrors and this volitility is part of the game if you want to get rich.
It sucks to see this kind of bleeding. But no huge investor has pulled out yet, they're waiting for the deciding factor (FDA). I won't be selling one share until that judgment.
That was the bet from day 1. Man up and see your choices through to the end.
-Teeth